Hepatitis C (often called “hep C”) is a viral infection that attacks the liver. An estimated 50 million people worldwide are living with it, and roughly 240,000 die each year from its complications. The good news: modern treatment cures more than 95% of cases in as little as 8 to 12 weeks of oral medication.
How Hepatitis C Spreads
Hepatitis C is a blood-borne virus. It spreads when blood from an infected person enters someone else’s bloodstream. The most common route by far is sharing needles, syringes, or other equipment used to inject drugs.
Less common routes include childbirth (mother to baby), sexual contact, tattooing in unregulated facilities, accidental needle sticks, and sharing personal items like razors or toothbrushes that may carry traces of blood. Before 1992, blood transfusions and organ transplants were a significant source of infection in the U.S., but routine screening of the blood supply has made that path extremely rare.
You cannot catch hepatitis C from casual contact, hugging, sharing food, or being near someone who coughs or sneezes.
Why Most People Don’t Know They Have It
Hepatitis C is sometimes called a “silent” infection because it often causes no noticeable symptoms for years or even decades. When symptoms do appear during the early (acute) phase, they can include fatigue, fever, joint pain, nausea, dark urine, clay-colored stools, loss of appetite, and jaundice, a yellowing of the skin and eyes. These look a lot like a generic flu or stomach illness, so many people never connect them to a liver infection.
The chronic stage is even quieter. Most people with long-term hepatitis C either feel nothing at all or experience vague, nonspecific problems like persistent fatigue and depression. Because these symptoms overlap with so many other conditions, it’s common for someone to carry the virus for 20 or 30 years without a diagnosis.
Acute vs. Chronic Infection
After initial exposure, the body enters an acute phase lasting roughly the first six months. A minority of people (about 15 to 45%) clear the virus on their own during this window, their immune system eliminating it without treatment. The rest, an estimated 55 to 85%, develop chronic hepatitis C, meaning the virus persists in the body indefinitely unless treated.
What Happens to the Liver Over Time
Chronic hepatitis C is a slow-moving disease, but it is not harmless. The virus triggers ongoing inflammation in the liver, and over years that inflammation gradually replaces healthy tissue with scar tissue (fibrosis). Without treatment, about 15 to 25% of chronically infected people develop cirrhosis, severe scarring that impairs the liver’s ability to function, within 25 to 30 years.
Cirrhosis is the stage where serious complications cluster. Among people who reach cirrhosis, roughly 20% go on to develop liver cancer. Nearly 90% of hepatitis C-related liver cancers arise in people who already have advanced scarring or cirrhosis, typically after two to three decades of infection. This long, quiet timeline is exactly why early detection matters so much: catching the virus before significant liver damage has occurred changes the outcome dramatically.
How Testing Works
Diagnosing hepatitis C requires two steps, and both can be done from a single blood draw. The first is an antibody test. Your immune system produces antibodies against the virus, and this test checks whether those antibodies are present. A positive result means you’ve been exposed to hepatitis C at some point, but it doesn’t tell you whether the infection is still active. Some people who cleared the virus years ago will still test positive for antibodies.
If the antibody test is positive, the lab runs a second test that looks for the virus’s genetic material (RNA) in your blood. If RNA is detected, you have a current, active infection. If no RNA is found, you were likely exposed in the past but your body cleared the virus or you were previously treated and cured.
The CDC recommends that all adults aged 18 and older get screened at least once in their lifetime. People with ongoing risk factors, such as current injection drug use, should be tested more regularly.
Treatment and Cure Rates
Hepatitis C is one of the few chronic viral infections that can be completely cured. The standard treatment is a course of pills called direct-acting antivirals, taken daily for 8 to 12 weeks depending on the specific virus genotype and how much liver damage is present. There are no injections involved, and side effects are generally mild compared to the older interferon-based treatments that were used before 2014.
In a large U.S. study of over 6,600 treated patients, 97.3% achieved what’s known as a sustained virologic response, meaning no detectable virus remained in their blood 12 weeks after finishing treatment. At that point, the infection is considered cured. The virus does not hide and reactivate the way some other viruses do. However, being cured does not make you immune. You can be reinfected if you’re exposed again.
Liver damage that occurred before treatment doesn’t fully reverse, especially if cirrhosis has already set in. That’s the strongest argument for early testing: the sooner you treat, the less permanent damage the virus has time to cause.
Prevention Without a Vaccine
There is currently no vaccine for hepatitis C. Despite decades of research, the virus mutates rapidly enough that developing an effective vaccine remains one of the major unsolved challenges in infectious disease. (Vaccines do exist for hepatitis A and hepatitis B, which are different viruses.)
Prevention comes down to avoiding blood-to-blood contact with an infected person. The most effective steps include never sharing needles or syringes, using only licensed tattoo and piercing facilities that follow proper sterilization procedures, and not sharing personal items like razors or nail clippers that could carry small amounts of blood. For healthcare workers, standard precautions around needles and sharps remain the primary safeguard.